Meeks JJ, van der Heijden MS, Powles T, Galsky MD, et al. PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum. J Urol 2025;214:556.
PMID: 41065094